Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk's CEO took the Washington hot seat over Ozempic prices. 3 takeaways from his testimony
CEO Lars Fruergaard Jørgensen agreed today, during a Senate committee hearing, to sit down with lawmakers and pharmacy benefit managers (PBMs) to look into the possibility of cutting list prices for the company’s popular diabetes and weight-loss drugs.
Novo Nordisk boss in US grilling over prices for weight-loss drugs
Novo Nordisk has been criticised by US politicians for the high pricing of its popular weight-loss and diabetes drugs. But CEO Lars Fruergaard Jørgensen has defended the company, attributing the elevated prices to "structural issues" within the US healthcare system.
Sanders, Novo Nordisk CEO clash over Ozempic, Wegovy drug prices
The CEO of Novo Nordisk wouldn’t commit to lowering the prices of Ozempic and Wegovy during a Senate hearing Tuesday, despite repeatedly being pressed by Senate Health Committee Chair Bernie
‘You’re hiding behind your opaqueness’: Senators question Novo Nordisk CEO over high cost of Ozempic, Wegovy
Bipartisan lawmakers grilled Novo Nordisk CEO Lars Fruergaard Jørgensen in a Senate hearing in an attempt to pick apart the high cost of GLP-1 drugs.
Why does Ozempic cost so much? Senators grilled Novo Nordisk CEO for answers.
Novo Nordisk CEO grilled over company's pricing for the diabetes drug Ozempic and the weight-loss drug Wegovy.
Ozempic CEO agrees to discuss lower prices for blockbuster weight loss drugs
Is Ozempic and Wegovy maker Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO testified on Capitol Hill Tuesday.
Ozempic maker to testify before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
Ozempic, Wegovy maker Novo Nordisk questioned over high cost of weight-loss drugs
U.S. senators questioned Novo Nordisk CEO Lars Fruergaard Jørgensen about the high costs of the company's GLP-1 drugs, which include popular weight-loss drugs Wegovy and Ozempic. It comes after North Carolina cut the weight-loss drugs from its state health plan.
Novo CEO pressed by Senate to cut prices of obesity, diabetes drugs
CEO Lars Fruergaard Jørgensen told lawmakers the company would consider new talks with insurers about the list prices of Wegovy and Ozempic if they pledge to keep the medicines on their formularies.
Ozempic maker testifies before Senate committee on weight loss drug prices
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on Tuesday.
Novo Nordisk CEO Stands by Drug Pricing of Ozempic, Wegovy
Novo Nordisk Chief Executive Lars Jorgensen challenged Medicare's new role negotiating prescription drug prices during his testimony before a Senate committee on the company's blockbuster diabetes and weight-loss drugs.
FiercePharma
11h
With Novo CEO on the hot seat at Senate hearing, PBMs and insurance concerns get the spotlight
When government officials and politicians scrutinize high U.S. drug prices, the role of insurers and pharmacy benefit ...
Copenhagen Post
1h
Novo Nordisk CEO: “We can’t solve the problem of expensive medicine alone”
While both Danes and the Danish government seem pleased with Novo Nordisk and the company’s enormous earnings, the large ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Would-be assassin charged
Gets 2-yrs for role in fraud
Woman dies in 'suicide pod’
Food packaging cancer risk
Outlaws guitarist dies
Haitian group files complaint
‘Trump Train’ jury verdict
Phoenix breaks heat record
To shut down TikTok Music
Penn suspends law professor
Executed by lethal injection
Rioter mistakenly released
1st NL East title since 2011
Partners with Google
X account hacked
EEOC blocked on rules
Pac-12 sues Mountain West
Dali owner, operator sued
NC sending absentee ballots
PA county ballot ruling
Johnny Cash statue unveiled
ISR: Hezbollah leader killed
Severe obesity on the rise
Retiring after 14 seasons
InfoWars to be auctioned off
Recalls 41K+ motorcycles
Study about oceans' acidity
OR removes 1,200+ voters
Calls strike against 'LoL’
Pres candidates' security bill
US to waive visas for Qatar
NYC schools boss retiring
$375M military aid to UKR
Union gets more voting time
Related topics
Ozempic
Novo Nordisk
United States Senate
Bernie Sanders
Wegovy
Feedback